XOMA Royalty and LAVA Therapeutics Reveal Changes to Purchase Agreement

Written by Emily J. Thompson, Senior Investment Analyst

LVTX%

Source: Globenewswire

Updated: Oct 17 2025

0mins

Source: Globenewswire

Amendment Details: LAVA Therapeutics and XOMA Royalty Corporation have amended their share purchase agreement, reducing the initial cash amount per share to $1.04 and updating the contingent value rights (CVR) terms, including a new right to receive additional cash based on potential liabilities.
Extended Offer Timeline: The tender offer for LAVA shares has been extended to November 12, 2025, with the acquisition expected to close in the fourth quarter of 2025, pending customary closing conditions and shareholder approvals.
Extraordinary General Meeting: LAVA will reconvene its Extraordinary General Meeting of Shareholders on November 7, 2025, to approve resolutions related to the transactions with XOMA Royalty, which were previously scheduled for September 30, 2025.
Forward-Looking Statements: Both companies have issued cautionary notes regarding forward-looking statements, highlighting potential risks and uncertainties that could affect the completion and benefits of the transactions.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

XOMA Royalty and LAVA Therapeutics Reveal Changes to Purchase Agreement

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Trump Denies Considering JPMorgan's Dimon for Fed Chair Position

General Motors Increases Dividend by 25% and Launches $6 Billion Buyback Program

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch